-
Comprehensive clinical sequencing opens door to the promise of precision medicine
07/23/2021
St. Jude Children’s Research Hospital study highlights the power of comprehensive whole genome, whole exome and RNA sequencing to better understand and treat each patient’s cancer.
-
Research illuminates earliest part of phase separation
07/23/2021
St. Jude scientists study how phase separation begins on a microsecond time scale, showing how the earliest events with individual molecules impact assembly speed.
-
St. Jude JAM launches online auction
07/22/2021
Now through Aug. 3, bidding is open for an online auction affiliated with the St. Jude JAM Presented by Delta Dental of Tennessee and HH Global, a virtual concert event for St. Jude Children’s Research Hospital® at 5:30 p.m. CT on Tuesday, Aug. 3, at Radians Amphitheater at Memphis Botanic Garden.
-
Chemotherapy can induce mutations that lead to pediatric leukemia relapse
07/22/2021
A collaboration led by St. Jude Children’s Research Hospital, Shanghai Children’s Medical Center and others revealed how thiopurines produce mutations that lead to multi-drug resistant leukemia and relapse.
-
Scientists link frailty and neurocognitive decline in childhood cancer survivors
07/20/2021
St. Jude Children’s Research Hospital scientists have shown that frailty contributes to neurocognitive decline in young adult survivors of childhood cancer.
-
Bill Greene, PharmD, of St. Jude receives award for outstanding contributions to the pharmacy profession
07/20/2021
William L. “Bill” Greene, PharmD, chief pharmaceutical officer, to receive the 2021 Shelby Rhinehart Public Service Lifetime Achievement Award.
-
Molecules in motion: researchers capture six new structures of the ribosome in action
07/07/2021
St. Jude Children’s scientists have used smFRET and cyro-EM to capture structures of a biologic process through research that has implications for antibiotic development.
-
Discovery shows how tuning the immune system may enhance vaccines and ease disease
07/07/2021
A metabolic control pathway that regulates T follicular helper cells offers targets for drugs to stimulate the adaptive immune response.
-
Genetic factors linked to response to common antiviral medications
07/07/2021
Scientists at St. Jude and international collaborators have shown that the enzyme NUDT15 metabolizes ganciclovir and acyclovir, with genetic variants in this gene affecting how patients respond to these drugs.
-
Melanoma registry results shine light on rare pediatric cancer
07/06/2021
St. Jude Children’s Research Hospital scientists created a registry for molecular analysis of pediatric melanoma that provides insight into treatment.
-
Studies reveal key process needed for cells to recover from stress
06/24/2021
A pair of papers from St. Jude Children’s Research Hospital shows ubiquitination is needed for disassembly of stress granules, which are linked to neurodegenerative diseases.
-
PAWS for St. Jude forms dog packs
06/22/2021
PAWS for St. Jude is holding a light-hearted fundraising competition where participants capture photos and video using the hashtag #PAWSforStJude to raise awareness and support for the hospital.
-
Analysis reveals origins of a leukemia that straddles diagnostic categories
06/18/2021
Research led by St. Jude and the Munich Leukemia Laboratory highlights molecular analysis as an approach to improve classification and diagnosis of acute leukemia.
-
University of Memphis to Launch Online Master of Nonprofit Management
06/14/2021
The Tennessee Higher Education Commission recently approved a new online Master of Nonprofit Management (MNM) at the University of Memphis designed in collaboration with ALSAC/ St. Jude.
-
Structure of enzyme that causes Parkinson’s promises pathways to new drugs
06/08/2021
Enzyme LRRK2 is a biological switch whose mutation generates abnormal proteins in Parkinson’s patients.
-
Erica Sirrine named director of Social Work at St. Jude Children's Research Hospital
06/07/2021
Grief and bereavement expert with years of building social work programs in academia will direct a growing program at St. Jude.
-
Content creators on Twitch raise $4 million in one month for St. Jude
06/03/2021
Thousands of content creators from around the world joined St. Jude PLAY LIVE® to raise a record-breaking $4 million for in May, 2021.
-
Gene therapy appears more cost effective than current treatments for severe hemophilia B
06/03/2021
St. Jude Children’s Research Hospital provides the first gene therapy manufacturing and distribution cost report for hemophilia B.
-
FedEx St. Jude Angels & Stars Giving Campaign runs now through June 30
06/02/2021
The FedEx St. Jude Angels & Stars Giving Campaign for St. Jude Children’s Research Hospital® is live through June 30, with an online auction on June 10.
-
Red Roses for St. Jude: A Live Virtual Benefit Concert with AJ Rafael and Friends
06/02/2021
Red Roses for St. Jude will feature a line-up of leading Filipino artists, including AJ Rafael who plan to announce their donation totals to inspire fans.
-
St. Jude Children’s Research Hospital research featured at ASCO annual meeting
06/01/2021
Scientists from St. Jude Children’s Research Hospital will present their original research and share their expertise at the American Society of Clinical Oncology (ASCO) annual meeting.
-
Legends for Charity raises $900,000 for St. Jude
05/25/2021
One hundred generous supporters raised $900,000 for the kids of St. Jude at this year’s Legends for Charity Dinner, which took place on May 15 at the Tampa home of event co-chairs Drew and Morgan Weatherford.
-
St. Jude, other top U.S. cancer centers call for urgent action to get cancer-preventing HPV vaccination on track
05/20/2021
The COVID-19 pandemic has interrupted delivery of key health services for children and adolescents, including HPV vaccination for cancer prevention.
-
M. Madan Babu elected to U.K. Academy of Medical Sciences
05/12/2021
St. Jude director of Center of Excellence for Data Driven Discovery named a fellow of British medical association.
-
Researchers speed identification of DNA regions that regulate gene expression
05/06/2021
St. Jude scientists have developed a highly efficient method to address a major challenge in biology—identifying the genetic ‘switches’ that regulate gene expression.
-
COVID-19 vaccine is associated with fewer asymptomatic SARS-CoV-2 infections
05/06/2021
St. Jude COVID-19 screening and vaccination program for employees offers early evidence that vaccine protects against asymptomatic infection, which has fueled the pandemic.
-
St. Jude patient Von announces Round 2 selection during 2021 NFL Draft
04/29/2021
St. Jude patient Von will announce the Indianapolis Colts’ Round 2 pick with NFL Commissioner Roger Goodell during the 2021 NFL Draft, beginning on Thursday, April 29.
-
St. Jude influenza research earns renewed NIH funding
04/28/2021
Centers of Excellence for Influenza Research and Response at St. Jude earns nearly $9 million in funding.
-
St. Jude Children’s Research Hospital announces largest strategic expansion in its history targeting pediatric catastrophic diseases globally
04/27/2021
Six-year plan to invest $11.5 billion with donor support to accelerate research and treatment worldwide.
-
Risk-directed childhood leukemia treatment takes a step forward
04/10/2021
St. Jude findings highlight genomic analysis as a tool to extend risk-directed therapy and improve outcomes for children with the most common pediatric cancer.
